Chuikyo Discussing Admission Fee for Schizophrenia Patients on Drug Clozapine, Eyeing Transition to Home

November 21, 2019
Chuikyo General Meeting on November 20 The Ministry of Health, Labor and Welfare (MHLW) called for discussions on the home transition rate of patients on Novartis Pharma’s schizophrenia drug clozapine (original product: Clozaril) in relation to the psychiatric acute care...read more